(Q36608648)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

NK-cell and T-cell functions in patients with breast cancer: effects of surgery and adjuvant chemo- and radiotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

Adaptive radiation therapy

31 December 2019

main subject

0 references

author

Fariba Mozaffari

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

C Lindemalm

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

A Choudhury

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

H Granstam-Björneklett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

I Helander

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

M Lekander

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

E Mikaelsson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

B Nilsson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

M-L Ojutkangas

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

A Osterborg

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

L Bergkvist

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

H Mellstedt

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

5 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Cancer

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

105-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6603840

31 December 2019

exact match

0 references

cites work

Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Thymic regulatory T cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Immune tolerance in breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

The changing global patterns of female breast cancer incidence and mortality

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Current status and future directions in breast cancer therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17‐1A

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Technology evaluation: Theratope, Biomira Inc.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Evidence for immune defects in breast and lung cancer patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2359666

Interleukin-2 augments natural killer cell activity

21 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6603840

Th2/Th1 switch induced by a single low dose of cyclophosphamide in a rat metastatic lymphoma model

21 January 2018

1 reference

12 December 2020

Impaired antibody-dependent cellular cytotoxicity mediated by herceptin in patients with gastric cancer

1 reference

12 December 2020

Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer

1 reference

12 December 2020

Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancer

1 reference

12 December 2020

Pilot Study of the Mechanism of Action of Preoperative Trastuzumab in Patients with Primary Operable Breast Tumors Overexpressing HER2

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Influence of local radiotherapy of breast cancer patients on the frequency of cytotoxic T lymphocyte precursor cells

1 reference

12 December 2020

Evaluation of different effects of sera of breast cancer patients on the activity of natural killer cells

1 reference

12 December 2020

Cell-mediated immunity in breast cancer patients

1 reference

12 December 2020

Peripheral T lymphocytes from women with breast cancer exhibit abnormal protein expression of several signaling molecules

1 reference

12 December 2020

Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6603840

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17551492%20AND%20SRC:MED&resulttype=core&format=json